Concussion, Mild
95
10
15
54
Key Insights
Highlights
Success Rate
92% trial completion (above average)
Research Maturity
54 completed trials (57% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
5.3%
5 terminated out of 95 trials
91.5%
+5.0% vs benchmark
0%
0 trials in Phase 3/4
19%
10 of 54 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 54 completed trials
Clinical Trials (95)
Acceptance and Commitment Therapy Integrated Vestibular Rehabilitation (ACTIVE) RCT
GAIN Symptoms: Post-traumatic Headache
Use of Tinted Contact Lenses for Concussion-Related Light Sensitivity
Eye Recovery Automation for Post Injury Dysfunction (iRAPID)
Mindfulness-Based Intervention for Pediatric Mild Traumatic Brain Injury
Poly-omic Predictors of Symptom Duration and Recovery for Adolescent Concussion
Concussion Treatment in Older Adults
Rapid, Accurate, Cost-effective Assessment of Blood Biomarkers for Diagnosis of Concussion
Persistent Post-Concussion Symptoms With Convergence Insufficiency
The Exercise and Concussion Health Study
Female Concussion Head Cooling
Yoga and Female Concussion
Predicting Concussion Outcomes With Salivary miRNA
Targeted Multidomain (T-MD) Interventions for Complex Mild Traumatic Brain Injury (mTBI)
Turkish Translation of SportsConcussion Assesment Tool 6
Interdisciplinary Interventions After mTBI
Improving In-hospital and Post-discharge Patient Education for Mild Traumatic Brain Injury
Facilitating Access to Specialty Treatment
BCAAs in Concussion 2.0
SMART-CPT for PTSD/Concussion Implementation